{
 "drug": "Carboplatin Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "04/28/2023",
 "dayN": 1215,
 "cat": "Oncology",
 "companies": [
  "Gland Pharma Limited",
  "Hospira, Inc., a Pfizer Company",
  "Accord Healthcare Inc.",
  "Ingenus Pharmaceuticals LLC",
  "Teyro Labs",
  "Teva Pharmaceuticals USA, Inc.",
  "Avyxa Pharma, LLC",
  "Eugia US LLC",
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [
  "Demand increase for the drug",
  "Other",
  "Requirements related to complying with good manufacturing practices",
  "Discontinuation of the manufacture of the drug",
  "Delay in shipping of the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "54288-166-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC",
   "openfda": {
    "application_number": [
     "ANDA207324"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "BPI Labs LLC"
    ],
    "product_ndc": [
     "54288-166",
     "54288-165",
     "54288-167",
     "54288-164"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "c0a7463c-d90f-4060-a54e-6a4888e8af0e"
    ],
    "spl_set_id": [
     "5484d2f0-0cc2-4bba-8f26-c7f6539a9606"
    ],
    "package_ndc": [
     "54288-165-01",
     "54288-166-01",
     "54288-167-01",
     "54288-164-01"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)",
   "company_name": "Gland Pharma Limited",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-150-05",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-150",
     "61703-360",
     "61703-262",
     "61703-600"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "5aa72c15-8033-4559-b257-373371b18958"
    ],
    "spl_set_id": [
     "47677091-fd20-49af-933c-c9dd2be21de9"
    ],
    "package_ndc": [
     "61703-360-18",
     "61703-150-05",
     "61703-262-05",
     "61703-600-05"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-339-18",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: February 2027; Estimated Recovery: March 2027",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-339"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0ddf4411-7138-412a-908a-fadf22bdfb79"
    ],
    "spl_set_id": [
     "c3ae9880-44bb-4f4e-93d8-8a5e21708a30"
    ],
    "package_ndc": [
     "61703-339-18",
     "61703-339-22",
     "61703-339-50",
     "61703-339-56"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "16729-295-12",
   "generic_name": "Carboplatin Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD; NDC is non-exempt",
   "openfda": {
    "application_number": [
     "ANDA206775"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc."
    ],
    "product_ndc": [
     "16729-295"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "35cf6068-f31a-211b-e063-6294a90a6b53"
    ],
    "spl_set_id": [
     "48aa7ef3-9f44-2a08-e054-00144ff88e88"
    ],
    "package_ndc": [
     "16729-295-31",
     "16729-295-33",
     "16729-295-34",
     "16729-295-12",
     "16729-295-38"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "discontinued_date": "02/20/2026",
   "update_type": "New",
   "initial_posting_date": "02/20/2026",
   "package_ndc": "50742-447-45",
   "generic_name": "Carboplatin Injection",
   "contact_info": "866-321-5031",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "02/20/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)",
   "company_name": "Ingenus Pharmaceuticals LLC",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-339-22",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-339"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0ddf4411-7138-412a-908a-fadf22bdfb79"
    ],
    "spl_set_id": [
     "c3ae9880-44bb-4f4e-93d8-8a5e21708a30"
    ],
    "package_ndc": [
     "61703-339-18",
     "61703-339-22",
     "61703-339-50",
     "61703-339-56"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "60505-6282-3",
   "generic_name": "Carboplatin Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "availability": "Unavailable",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)",
   "company_name": "Teyro Labs",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "54288-165-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC",
   "openfda": {
    "application_number": [
     "ANDA207324"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "BPI Labs LLC"
    ],
    "product_ndc": [
     "54288-165",
     "54288-166",
     "54288-167",
     "54288-164"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "c0a7463c-d90f-4060-a54e-6a4888e8af0e"
    ],
    "spl_set_id": [
     "5484d2f0-0cc2-4bba-8f26-c7f6539a9606"
    ],
    "package_ndc": [
     "54288-165-01",
     "54288-166-01",
     "54288-167-01",
     "54288-164-01"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)",
   "company_name": "Gland Pharma Limited",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-339-56",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-339"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0ddf4411-7138-412a-908a-fadf22bdfb79"
    ],
    "spl_set_id": [
     "c3ae9880-44bb-4f4e-93d8-8a5e21708a30"
    ],
    "package_ndc": [
     "61703-339-18",
     "61703-339-22",
     "61703-339-50",
     "61703-339-56"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-360-18",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-360",
     "61703-150",
     "61703-262",
     "61703-600"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "5aa72c15-8033-4559-b257-373371b18958"
    ],
    "spl_set_id": [
     "47677091-fd20-49af-933c-c9dd2be21de9"
    ],
    "package_ndc": [
     "61703-360-18",
     "61703-150-05",
     "61703-262-05",
     "61703-600-05"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "0703-4246-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "800-545-8800",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: September 2026",
   "openfda": {
    "application_number": [
     "ANDA077269"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-4246",
     "0703-4244",
     "0703-4248",
     "0703-4239"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df",
     "b943761e-6a46-45a0-bdb4-1fec1e101f8c"
    ],
    "spl_set_id": [
     "f330f5a2-2cad-402f-bcbb-26245a753276",
     "e176b6ef-2ff6-498b-a9d8-7a634d147f37"
    ],
    "package_ndc": [
     "0703-4244-01",
     "0703-4246-01",
     "0703-4248-01",
     "0703-4239-01",
     "0703-4244-81",
     "0703-4246-81",
     "0703-4248-81",
     "0703-4239-81"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "0703-4239-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "800-545-8800",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: December 2028",
   "openfda": {
    "application_number": [
     "ANDA077269"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-4239",
     "0703-4244",
     "0703-4246",
     "0703-4248"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df",
     "b943761e-6a46-45a0-bdb4-1fec1e101f8c"
    ],
    "spl_set_id": [
     "f330f5a2-2cad-402f-bcbb-26245a753276",
     "e176b6ef-2ff6-498b-a9d8-7a634d147f37"
    ],
    "package_ndc": [
     "0703-4244-01",
     "0703-4246-01",
     "0703-4248-01",
     "0703-4239-01",
     "0703-4244-81",
     "0703-4246-81",
     "0703-4248-81",
     "0703-4239-81"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "discontinued_date": "02/20/2026",
   "update_type": "New",
   "initial_posting_date": "02/20/2026",
   "package_ndc": "50742-448-60",
   "generic_name": "Carboplatin Injection",
   "contact_info": "866-321-5031",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "02/20/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)",
   "company_name": "Ingenus Pharmaceuticals LLC",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "54288-167-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270",
   "availability": "Limited Availability",
   "related_info": "Distributed by BPI Labs, LLC",
   "openfda": {
    "application_number": [
     "ANDA207324"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "BPI Labs LLC"
    ],
    "product_ndc": [
     "54288-167",
     "54288-165",
     "54288-166",
     "54288-164"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "c0a7463c-d90f-4060-a54e-6a4888e8af0e"
    ],
    "spl_set_id": [
     "5484d2f0-0cc2-4bba-8f26-c7f6539a9606"
    ],
    "package_ndc": [
     "54288-165-01",
     "54288-166-01",
     "54288-167-01",
     "54288-164-01"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)",
   "company_name": "Gland Pharma Limited",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-339-50",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-339"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0ddf4411-7138-412a-908a-fadf22bdfb79"
    ],
    "spl_set_id": [
     "c3ae9880-44bb-4f4e-93d8-8a5e21708a30"
    ],
    "package_ndc": [
     "61703-339-18",
     "61703-339-22",
     "61703-339-50",
     "61703-339-56"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "0703-4248-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "800-545-8800",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: February 2027",
   "openfda": {
    "application_number": [
     "ANDA077269"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-4248",
     "0703-4244",
     "0703-4246",
     "0703-4239"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df",
     "b943761e-6a46-45a0-bdb4-1fec1e101f8c"
    ],
    "spl_set_id": [
     "f330f5a2-2cad-402f-bcbb-26245a753276",
     "e176b6ef-2ff6-498b-a9d8-7a634d147f37"
    ],
    "package_ndc": [
     "0703-4244-01",
     "0703-4246-01",
     "0703-4248-01",
     "0703-4239-01",
     "0703-4244-81",
     "0703-4246-81",
     "0703-4248-81",
     "0703-4239-81"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-600-05",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA077059"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-600",
     "61703-360",
     "61703-150",
     "61703-262"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "5aa72c15-8033-4559-b257-373371b18958"
    ],
    "spl_set_id": [
     "47677091-fd20-49af-933c-c9dd2be21de9"
    ],
    "package_ndc": [
     "61703-360-18",
     "61703-150-05",
     "61703-262-05",
     "61703-600-05"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "60505-6282-7",
   "generic_name": "Carboplatin Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "availability": "Unavailable",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)",
   "company_name": "Teyro Labs",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "60505-6282-6",
   "generic_name": "Carboplatin Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "availability": "Unavailable",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)",
   "company_name": "Teyro Labs",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "83831-142-50",
   "generic_name": "Carboplatin Injection",
   "contact_info": "877-595-7337; customerservice@avyxa.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA219921"
    ],
    "brand_name": [
     "KYXATA"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Avyxa Pharma, LLC"
    ],
    "product_ndc": [
     "83831-142",
     "83831-140",
     "83831-141"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195",
     "2721602"
    ],
    "spl_id": [
     "5c711945-70be-42f4-b153-e1459dd9929c"
    ],
    "spl_set_id": [
     "f91c48da-68d1-4aa7-89b8-d84a3e8b629b"
    ],
    "package_ndc": [
     "83831-140-02",
     "83831-141-08",
     "83831-142-50"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)",
   "company_name": "Avyxa Pharma, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "60505-6282-1",
   "generic_name": "Carboplatin Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Carboplatin%20Injection&st=d",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "availability": "Unavailable",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)",
   "company_name": "Teyro Labs",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "61703-262-05",
   "generic_name": "Carboplatin Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "ANDA076517"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "61703-262",
     "61703-360",
     "61703-150",
     "61703-600"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "5aa72c15-8033-4559-b257-373371b18958"
    ],
    "spl_set_id": [
     "47677091-fd20-49af-933c-c9dd2be21de9"
    ],
    "package_ndc": [
     "61703-360-18",
     "61703-150-05",
     "61703-262-05",
     "61703-600-05"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "0703-4244-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "800-545-8800",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: October 2026",
   "openfda": {
    "application_number": [
     "ANDA077269"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-4244",
     "0703-4246",
     "0703-4248",
     "0703-4239"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df",
     "b943761e-6a46-45a0-bdb4-1fec1e101f8c"
    ],
    "spl_set_id": [
     "f330f5a2-2cad-402f-bcbb-26245a753276",
     "e176b6ef-2ff6-498b-a9d8-7a634d147f37"
    ],
    "package_ndc": [
     "0703-4244-01",
     "0703-4246-01",
     "0703-4248-01",
     "0703-4239-01",
     "0703-4244-81",
     "0703-4246-81",
     "0703-4248-81",
     "0703-4239-81"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "16729-295-31",
   "generic_name": "Carboplatin Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA206775"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc."
    ],
    "product_ndc": [
     "16729-295"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "35cf6068-f31a-211b-e063-6294a90a6b53"
    ],
    "spl_set_id": [
     "48aa7ef3-9f44-2a08-e054-00144ff88e88"
    ],
    "package_ndc": [
     "16729-295-31",
     "16729-295-33",
     "16729-295-34",
     "16729-295-12",
     "16729-295-38"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "55150-335-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "888-238-7880",
   "availability": "Unavailable",
   "related_info": "On backorder. Recovery: TBD. Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA205487"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Eugia US LLC"
    ],
    "product_ndc": [
     "55150-335",
     "55150-333",
     "55150-334",
     "55150-386"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "6029d051-ee8d-44cc-8dae-b91c3385d4c3",
     "5abfcb87-bb02-4384-9c9d-7d0e3e809311"
    ],
    "spl_set_id": [
     "f5fe9a20-47a5-45b9-ab06-c6158d9b6aca",
     "5abfcb87-bb02-4384-9c9d-7d0e3e809311"
    ],
    "package_ndc": [
     "55150-333-01",
     "55150-334-01",
     "55150-335-01",
     "55150-386-01",
     "55150-335-00",
     "55150-386-00"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/06/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)",
   "company_name": "Eugia US LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "60505-6282-3",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)",
   "company_name": "Teyro Labs",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "83831-141-08",
   "generic_name": "Carboplatin Injection",
   "contact_info": "877-595-7337; customerservice@avyxa.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA219921"
    ],
    "brand_name": [
     "KYXATA"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Avyxa Pharma, LLC"
    ],
    "product_ndc": [
     "83831-141",
     "83831-140",
     "83831-142"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195",
     "2721602"
    ],
    "spl_id": [
     "5c711945-70be-42f4-b153-e1459dd9929c"
    ],
    "spl_set_id": [
     "f91c48da-68d1-4aa7-89b8-d84a3e8b629b"
    ],
    "package_ndc": [
     "83831-140-02",
     "83831-141-08",
     "83831-142-50"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)",
   "company_name": "Avyxa Pharma, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "16729-295-33",
   "generic_name": "Carboplatin Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD; NDC is non-exempt",
   "openfda": {
    "application_number": [
     "ANDA206775"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc."
    ],
    "product_ndc": [
     "16729-295"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "35cf6068-f31a-211b-e063-6294a90a6b53"
    ],
    "spl_set_id": [
     "48aa7ef3-9f44-2a08-e054-00144ff88e88"
    ],
    "package_ndc": [
     "16729-295-31",
     "16729-295-33",
     "16729-295-34",
     "16729-295-12",
     "16729-295-38"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "60505-6282-1",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)",
   "company_name": "Teyro Labs",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "63323-172-60",
   "generic_name": "Carboplatin Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release November 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA077266"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-172"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "3a1dd588-13b0-4d58-8d46-3a25a4fc6b40"
    ],
    "spl_set_id": [
     "b4fa7aac-c9d2-4af4-a281-3e6cfc502ff6"
    ],
    "package_ndc": [
     "63323-172-60"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Delay in shipping of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "16729-295-34",
   "generic_name": "Carboplatin Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD; NDC is non-exempt",
   "openfda": {
    "application_number": [
     "ANDA206775"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc."
    ],
    "product_ndc": [
     "16729-295"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "35cf6068-f31a-211b-e063-6294a90a6b53"
    ],
    "spl_set_id": [
     "48aa7ef3-9f44-2a08-e054-00144ff88e88"
    ],
    "package_ndc": [
     "16729-295-31",
     "16729-295-33",
     "16729-295-34",
     "16729-295-12",
     "16729-295-38"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "55150-386-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "888-238-7880",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA205487"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Eugia US LLC"
    ],
    "product_ndc": [
     "55150-386",
     "55150-333",
     "55150-334",
     "55150-335"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "6029d051-ee8d-44cc-8dae-b91c3385d4c3",
     "5abfcb87-bb02-4384-9c9d-7d0e3e809311"
    ],
    "spl_set_id": [
     "f5fe9a20-47a5-45b9-ab06-c6158d9b6aca",
     "5abfcb87-bb02-4384-9c9d-7d0e3e809311"
    ],
    "package_ndc": [
     "55150-333-01",
     "55150-334-01",
     "55150-335-01",
     "55150-386-01",
     "55150-335-00",
     "55150-386-00"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "08/06/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)",
   "company_name": "Eugia US LLC",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "60505-6282-7",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)",
   "company_name": "Teyro Labs",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "04/28/2023",
   "package_ndc": "54288-164-01",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Distributed by BPI Labs, LLC;  Customer service number:  (727) 471-0850 Ext 270",
   "availability": "Unavailable",
   "related_info": "Discontinued; Distributed by BPI Labs, LLC",
   "openfda": {
    "application_number": [
     "ANDA207324"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "BPI Labs LLC"
    ],
    "product_ndc": [
     "54288-164",
     "54288-165",
     "54288-166",
     "54288-167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "c0a7463c-d90f-4060-a54e-6a4888e8af0e"
    ],
    "spl_set_id": [
     "5484d2f0-0cc2-4bba-8f26-c7f6539a9606"
    ],
    "package_ndc": [
     "54288-165-01",
     "54288-166-01",
     "54288-167-01",
     "54288-164-01"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "07/22/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)",
   "company_name": "Gland Pharma Limited",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "60505-6282-6",
   "generic_name": "Carboplatin Injection",
   "contact_info": "Apotex Inc.: 800-706-5575",
   "related_info": "Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA077861"
    ],
    "brand_name": [
     "CARBOPLATIN"
    ],
    "generic_name": [
     "CARBOPLATIN"
    ],
    "manufacturer_name": [
     "Apotex Corp."
    ],
    "product_ndc": [
     "60505-6282"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CARBOPLATIN"
    ],
    "rxcui": [
     "597195"
    ],
    "spl_id": [
     "0e68e276-b0df-4f03-e063-6394a90a22b9"
    ],
    "spl_set_id": [
     "1c275825-0275-4c73-b650-e4c1519f13b8"
    ],
    "package_ndc": [
     "60505-6282-1",
     "60505-6282-3",
     "60505-6282-6",
     "60505-6282-7"
    ],
    "nui": [
     "N0000175413",
     "N0000175073"
    ],
    "pharm_class_epc": [
     "Platinum-based Drug [EPC]"
    ],
    "unii": [
     "BG3F62OND5"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Oncology"
   ],
   "dosage_form": "Injection",
   "presentation": "Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)",
   "company_name": "Teyro Labs",
   "status": "To Be Discontinued"
  }
 ]
}